Meeder Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
BBA
AC
CS
Meeder Asset Management's BLUE Position: Q4 2021 in Review
Meeder Asset Management sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 1 share.
Meeder Asset Management first reported a position in BLUE in Q2 2015 and held it in 16 quarters. The position peaked at $2.17M in Q2 2015. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.
- Meeder Asset Management reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
- Meeder Asset Management sold 1 bluebird bio share in Q4 2021.
- Meeder Asset Management first reported a position in bluebird bio in Q2 2015 and held it in 16 quarters.
- Meeder Asset Management's bluebird bio position peaked at $2.17M in Q2 2015.
- 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.
Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.